PMID- 35876649 OWN - NLM STAT- MEDLINE DCOM- 20220908 LR - 20221003 IS - 1935-5548 (Electronic) IS - 0149-5992 (Linking) VI - 45 IP - 9 DP - 2022 Sep 1 TI - Twenty-Year Temporal Trends in Risk of Ischemic Stroke in Incident Type 2 Diabetes: A Danish Population-Based Cohort Study. PG - 2144-2151 LID - 10.2337/dc22-0440 [doi] AB - OBJECTIVE: We examined temporal trends in risk of first-time ischemic stroke in patients with incident type 2 diabetes mellitus (T2DM) and no prior atherosclerotic cardiovascular disease (ASCVD). RESEARCH DESIGN AND METHODS: Using nationwide health registries, we identified all patients with incident T2DM without a prior hospital diagnosis of ASCVD from 1996 to 2015 in Denmark. Patients were assigned to 5-year periods based on the date of T2DM diagnosis and were followed for 5 years. Each patient was matched by sex and age with up to three individuals from the general population. Temporal trends in ischemic stroke were examined using Cox regression to compute hazard ratios (HRs). Temporal use of prophylactic cardiovascular medications was also assessed. RESULTS: The study comprised 288,825 patients with incident T2DM and 782,232 general population individuals. From 1996-2000 to 2011-2015, the 5-year risk of first-time ischemic stroke was approximately halved in the T2DM cohort (5.2% vs. 2.7%; sex- and age-adjusted HR 0.52 [95% CI 0.49-0.55]). Patients diagnosed in 2011-2015 had increased risk of ischemic stroke compared with individuals in the general population; however, the risk difference narrowed over time (5.2% vs. 2.9% in 1996-1999 [difference 2.3%]; 2.7% vs. 2.0% in 2011-2015 [difference 0.7%]). Use of prophylactic cardiovascular medications increased markedly during the overall study period, especially use of statins (from 5% to 50%) and multiple antihypertensive drugs (from 18% to 33%). CONCLUSIONS: From 1996 to 2015, the 5-year risk of first-time ischemic stroke was approximately halved in patients with incident T2DM and no prior ASCVD, coinciding with markedly increased use of prophylactic cardiovascular medications. CI - (c) 2022 by the American Diabetes Association. FAU - Gyldenkerne, Christine AU - Gyldenkerne C AUID- ORCID: 0000-0001-5904-7063 AD - Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. AD - Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark. FAU - Kahlert, Johnny AU - Kahlert J AD - Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark. FAU - Olesen, Kevin K W AU - Olesen KKW AD - Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. AD - Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark. FAU - Thrane, Pernille G AU - Thrane PG AD - Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. FAU - Sorensen, Henrik T AU - Sorensen HT AD - Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark. FAU - Thomsen, Reimar W AU - Thomsen RW AD - Department of Clinical Epidemiology, Department of Clinical Medicine, Aarhus University Hospital, Aarhus, Denmark. FAU - Maeng, Michael AU - Maeng M AD - Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark. LA - eng SI - figshare/10.2337/figshare.20198651 PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Diabetes Care JT - Diabetes care JID - 7805975 SB - IM MH - Cohort Studies MH - Denmark/epidemiology MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Humans MH - *Ischemic Stroke MH - Risk Factors MH - *Stroke/diagnosis/epidemiology/etiology EDAT- 2022/07/26 06:00 MHDA- 2022/09/09 06:00 CRDT- 2022/07/25 09:53 PHST- 2022/03/03 00:00 [received] PHST- 2022/06/12 00:00 [accepted] PHST- 2022/07/26 06:00 [pubmed] PHST- 2022/09/09 06:00 [medline] PHST- 2022/07/25 09:53 [entrez] AID - 147286 [pii] AID - 10.2337/dc22-0440 [doi] PST - ppublish SO - Diabetes Care. 2022 Sep 1;45(9):2144-2151. doi: 10.2337/dc22-0440.